FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

706899005: Umeclidinium bromide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2015. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3027579013 Umeclidinium bromide (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3027600016 Umeclidinium bromide en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Umeclidinium bromide Is a Umeclidinium false Inferred relationship Existential restriction modifier
Umeclidinium bromide Has disposition Muscarinic receptor antagonist true Inferred relationship Existential restriction modifier
Umeclidinium bromide Is a Quaternary ammonium compound with anticholinergic mechanism of action true Inferred relationship Existential restriction modifier
Umeclidinium bromide Is a Substance with muscarinic receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Umeclidinium bromide Is modification of Umeclidinium true Inferred relationship Existential restriction modifier
Umeclidinium bromide Is a Bronchodilator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Incruse Ellipta 55micrograms/dose dry powder inhaler (Ethigen Ltd) 30 dose Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Ethigen Ltd) Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler (Pharmaram Ltd) Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler (Pharmaram Ltd) 30 dose Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Pharmaram Ltd) 30 dose Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Pharmaram Ltd) Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (CST Pharma Ltd) Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (CST Pharma Ltd) 30 dose Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 30 dose Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (DE Pharmaceuticals) 30 dose Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (DE Pharmaceuticals) Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Rolufta Ellipta 55micrograms/dose dry powder inhaler (Ethigen Ltd) 30 dose Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Rolufta Ellipta 55micrograms/dose dry powder inhaler (Ethigen Ltd) Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose dry powder inhaler Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) 30 dose Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler 30 dose Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) 30 dose Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Ennogen Healthcare Ltd) Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Ennogen Healthcare Ltd) 30 dose Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (J M McGill Ltd) Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (J M McGill Ltd) 30 dose Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Generic Trelegy Ellipta 92micrograms/dose / 55micrograms/dose / 22micrograms/dose dry powder inhaler Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Trelegy Ellipta 92micrograms/dose / 55micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Generic Trelegy Ellipta 92micrograms/dose / 55micrograms/dose / 22micrograms/dose dry powder inhaler 30 dose Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier
Trelegy Ellipta 92micrograms/dose / 55micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) 30 dose Has specific active ingredient True Umeclidinium bromide Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start